Posts

AbbVie scores dual EU approvals for Rinvoq in vitiligo, alopecia

on

AbbVie Scores First Rinvoq Alopecia Nod in EU

on

Ionis scores transformational FDA label expansion for Tryngolza

on

Upstream Bio Stock Slides After Mixed Phase 2 Severe Asthma Trial Results

on

GSK wins FDA approval for ultra-long-acting asthma drug Exdensur (depemokimab)

on

Generate:Biomedicines Launches Global Phase 3 Trials for AI-Engineered Anti-TSLP Antibody GB-0895 in Severe Asthma

on

Gene Therapy Delivers Long-Term Immune Protection in Children With Rare Immune Disorders

on

Ionis Builds Case for Wider Tryngolza Use in Severe Lipid Disorders Following Positive Phase 3 Results

on

Sanofi Acquires China Rights to Arrowhead's Plozasiran for $395 Million

on

CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s

on

ACC25: Merck & Co.'s Winrevair reduces mortality in most severe PAH patients

on

Surrozen sets its sights on ophthalmology after binning liver programme

on